These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 1102521)

  • 61. [Beta blockade and angina pectoris. A double-blind trial].
    Hvidt S
    Ugeskr Laeger; 1970 Jun; 132(23):1077-80. PubMed ID: 5419638
    [No Abstract]   [Full Text] [Related]  

  • 62. [Penbutolol--a sinistrorotatory adrenergic beta-receptor blocking agent. Ergometer investigations in patients with angina pectoris].
    Prahl P; Prahl M
    Ugeskr Laeger; 1973 May; 135(20):965-8. PubMed ID: 4148295
    [No Abstract]   [Full Text] [Related]  

  • 63. A double-blind trial of hexobendine in the treatment of angina pectoris.
    Rosenstrauch WJ; Bosman AR; Brink AJ
    S Afr Med J; 1968 Aug; 42(31):818-9. PubMed ID: 4878931
    [No Abstract]   [Full Text] [Related]  

  • 64. [Exercise test in the evaluation of effectiveness of 4 antianginal drugs (author's transl)].
    Figini A; De Ponti C; Campolo L
    G Ital Cardiol; 1974; 4(3):289-95. PubMed ID: 4152383
    [No Abstract]   [Full Text] [Related]  

  • 65. [Use of Eraldine].
    Pauchant M
    Lille Med; 1974 Oct; 19(8 Suppl 3):867-9. PubMed ID: 4463282
    [No Abstract]   [Full Text] [Related]  

  • 66. [Perhexiline maleate in angina pectoris. Cross double blind evaluation controlled with placebo].
    Cunha GP; Lopes M; Maranhão MF; Rojas R
    Arq Bras Cardiol; 1973 Aug; 26 Suppl 1():93-6. PubMed ID: 4595482
    [No Abstract]   [Full Text] [Related]  

  • 67. [Importance of the placebo in the clinical evaluation of so-called coronary vasodilator agents in patients with clinical manifestations of angina pectoris].
    Calandre L; Ruano JM
    Rev Esp Cardiol; 1965 Apr; 18(2):168-72. PubMed ID: 5319557
    [No Abstract]   [Full Text] [Related]  

  • 68. Sotalol in the treatment of angina pectoris. A double-blind cross-over study.
    Kentala E; Pyörälä K; Frick MH
    Ann Clin Res; 1974 Oct; 6(5):253-7. PubMed ID: 4614692
    [No Abstract]   [Full Text] [Related]  

  • 69. [Eraldin: a cardioselective beta-adrenergic receptor blocking agent in the treatment of angina pectoris].
    Musial W; Krzemińska-Pakula M; Tracz W
    Pol Tyg Lek; 1971 Aug; 26(34):1316-8. PubMed ID: 4398697
    [No Abstract]   [Full Text] [Related]  

  • 70. [The treatment of angina pectoris with beta receptor blockaders].
    Kaltenbach M; Becker HJ; Graef V; Hunscha H
    Med Klin; 1971 Mar; 65(11):494-500. PubMed ID: 4996983
    [No Abstract]   [Full Text] [Related]  

  • 71. A double blind cross-over comparison of bunitrolol and placebo in the treatment of angina pectoris.
    Jonker JJ; de Klerk J; den Ottolander GJ
    Arzneimittelforschung; 1981; 31(7):1140-2. PubMed ID: 6115654
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Diuretic treatment in angina pectoris].
    De Bonis P; Cerruti P; Solani G; Teggia L
    Boll Soc Ital Cardiol; 1975; 20(11):1513-8. PubMed ID: 791306
    [No Abstract]   [Full Text] [Related]  

  • 73. [Skin and ocular lesions following long-term treatment with practolol (Eraldin)].
    Mikkelsen HI; Jensen HA; Wadskov S; Sondergaard J
    Ugeskr Laeger; 1975 Sep; 137(38):2188-91. PubMed ID: 1166556
    [No Abstract]   [Full Text] [Related]  

  • 74. Practolol in angina.
    Phear DN
    Br Med J; 1971 Mar; 1(5748):557. PubMed ID: 4396083
    [No Abstract]   [Full Text] [Related]  

  • 75. [Efficiency of Cormelian in coronary insufficiency. Results of a double-blind study].
    Gillner H; Pollter J; Schnitker J; Sievers HG; Zylmann G
    Med Monatsschr; 1975 Feb; 29(2):82-7. PubMed ID: 1092990
    [No Abstract]   [Full Text] [Related]  

  • 76. [Practolol in the treatment of withdrawal symptoms].
    Bogdanowicz E; Bojdecki K; Golabek M; Pacowska A; Puzyński S
    Psychiatr Pol; 1975; 9(3):289-95. PubMed ID: 1098077
    [No Abstract]   [Full Text] [Related]  

  • 77. A new coronary cardio-active compound in angina pectoris.
    Kundu SC; De TK; Majumdar S; Bhattacherjee TD; Mukerjee AB
    J Indian Med Assoc; 1975 Sep; 65(5):136-43. PubMed ID: 765401
    [No Abstract]   [Full Text] [Related]  

  • 78. Sclerosing peritonitis and practolol therapy.
    Cook AI; Foy P
    Ann R Coll Surg Engl; 1976 Nov; 58(6):473-5. PubMed ID: 984691
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Sclerosing peritonitis, an unusual reaction to a beta-adrenergic-blocking drug (practolol).
    Brown P; Baddeley H; Read AE; Davies JD; McGarry J
    Lancet; 1974 Dec; 2(7895):1477-81. PubMed ID: 4140395
    [No Abstract]   [Full Text] [Related]  

  • 80. Prognosis of angina pectoris.
    Miller HC
    Scott Med J; 1977 Jan; 22(1):47-51. PubMed ID: 13494
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.